The Paris Bourse ended two consecutive sessions of decline, with a rebound that could well be essentially technical and fragile. After having opened up almost 1% and having experienced a little slack at the end of the morning, the Cac 40 regained height, helped by Wall Street, to finish at 6,964.99 points, up 1, 38%.
However, this increase must be put into perspective by lower trade volumes than the day before, the day of decline, at 3.3 billion euros. The approach of the end of the year holidays has something to do with it. But it also testifies to the fragility of the rebound. Doubts are more than legitimate about the strength of economic growth as the Omicron variant continues to advance, prompting many countries to adopt restrictive measures. US President Joe Biden is due to address the nation tonight on the health issue.
According to White House spokeswoman Jen Psaki, containment is not on the agenda. For Mark Hackett, head of investment research at Nationwide, the multiplicity of Omicron variant cases, persistent supply problems, the failure of Joe Biden’s Build Back Better plan, increased volatility and thinner trading volumes in this shortened week ” are likely to cause the market to overreact, which could be a buying opportunity in the last few days leading up to Christmas “.
Bolloré in exclusive negotiations with MSC
On the stocks side, cyclicals and banks, traditionally the quickest to profit from cheap buying, or those most affected by fears about the Omicron variant, were among the strongest gains of the session. . The steelmaker ArcelorMittal and the commercial property Unibail-Rodamco-Westfield gained 2.81% and 3.82% respectively.
Sanofi (+ 0.9%) strengthens its portfolio in immuno-oncology, by acquiring the American company Amunix. The transaction includes an upfront payment of $ 1 billion, along with € 225 million in milestone payments based on the achievement of certain development goals. This acquisition is part of the initiatives undertaken by the French laboratory to step up its contribution to the R&D of innovative drugs for cancer patients, with around 20 molecules currently in development.
The values of the galaxy Bollore climbed in unison on Tuesday. The group led by Vincent Bolloré received an offer of 5.7 billion euros from the Swiss group MSC for the 100% takeover of its subsidiary Africa Logistics, which is more than the amount mentioned in the press in the past (2 to 3 billion). The group has granted exclusivity to MSC until March 31, 2022 so that the latter can give it a promise to purchase. On the stock market, Bolloré shares gained 11.54% and Odet Company, which owns 63% of Bolloré, took 17.21%.
Finally, DBV Technologies fell 37.71%. The biotech has decided to carry out a new pivotal phase III clinical study to answer all the questions raised by regulatory agencies about the potential of its Viaskin Peanut patch, its flagship desensitization treatment against peanut allergies.
CP